 Concomitant ganciclovir zidovudine treatment cytomegalovirus retinitis patients HIV infection approach treatment Cytomegalovirus CMV retinitis common cause blindness patients human immunodeficiency virus HIV Ganciclovir guanosine nucleoside effective short-term treatment CMV retinitis delay progression recurrence disease ganciclovir intrinsic activity HIV patients immune deficiency syndrome treatment zidovudine therapy HIV infection agents dose-limiting granulocytopenia patients death sepsis setting profound decreases absolute granulocyte counts recent investigation careful patient selection monitoring safe concomitant therapy possible article toxicity issues decision concomitant therapy ganciclovir zidovudine approach ganciclovir schema zidovudine dosage hematologic status prospective study way combined therapy patients survival decreased incidence recurrence active CMV retinitis